Rand tumbles most among peers as Zuma seeks to dodge exit calls

FILE President Jacob Zuma addresses delegates at the ANC's 54th national conference at Nasrec on 16 December 2017

Yet, despite all of Zuma's indiscretions, Ramaphosa has failed to recall him showing that the ANC will not self-correct and that we can only expect more of the same.

President Jacob Zuma's statement, issued on the eve of a high-level ruling party meeting where his fate is a certain topic of discussion, said any further delay will make the public doubt the government's resolve to fight graft. Sources inside the national executive committee had told News24 that Ramaphosa was scheduled to meet with Zuma during his visit to KwaZulu-Natal on the weekend.

The allegations that the State has been usurped from the hands of its real owners, the people of South Africa, is of great relevance and therefore requires determination and security, so I decided that this matter can not wait any longer, adds the statement signed by the President.

Magashule said the president and the president of the ANC are "meeting and engaging".

However, eNCA senior researcher Angelo Fick believes that despite the two centres of power between Luthuli House and the Union Buildings, the party will likely settle for unity.

The ruling party has until Friday to respond to the letter, which Transform RSA says goes beyond the ANC's first meeting of its newly-elected NEC, which was held on Wednesday.

The sources all agreed that it was now a matter of when, and not if, Zuma stepped down.

According to a report from Bloomberg, Zuma's early exit has been factored into the price of the rand since Ramaphosa won the election to become the new party leader in December 2017.



Latest news

AMGN) — Amgen Inc. (NASDAQ
Mizuho reiterated a "buy" rating and issued a $198.00 price target on shares of Amgen in a research note on Friday, October 6th. This buyback authorization authorizes the medical research company to buy shares of its stock through open market purchases.

Hot Stock for Investors: Amicus Therapeutics, Inc. (FOLD)
The stock, as of last close, traded 175.35% away to its 52 week low and was at a distance of -15.90% from its 52 week high. Amicus Therapeutics (NASDAQ:FOLD) last released its quarterly earnings data on Wednesday, November 8th.

England refrains from major changes for New Zealand tests
Of the 16 players in England's squad , seven were involved in the Ashes , while only four played all five Tests. For Bayliss's sake - and that of the European Central Bank - one must hope that they do.

Columbia Property Trust (NYSE:CXP) Earning Somewhat Favorable Media Coverage, Study Shows
It fall, as 55 investors sold ABBV shares while 640 reduced holdings. 31 funds opened positions while 20 raised stakes. The real estate investment trust reported $0.28 EPS for the quarter, beating the consensus estimate of $0.02 by $0.26.

Celebrities Who Suffer With Chronic Diseases
Now if that isn’t the epitome of what a BFF is, I don’t know what is! Selena continues to be on chronic medication. There is also a huge list of celebrities past like famous painter vincent Van Gogh who suffered with this disease.

Other news